Mono Pharmacare Management
Management criteria checks 2/4
Mono Pharmacare's CEO is Panilam Lakhatariya, appointed in Mar 2023, has a tenure of 1.67 years. directly owns 45.44% of the company’s shares, worth ₹279.77M. The average tenure of the management team and the board of directors is 1.9 years and 1.7 years respectively.
Key information
Panilam Lakhatariya
Chief executive officer
₹1.2m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.7yrs |
| CEO ownership | 45.4% |
| Management average tenure | 1.9yrs |
| Board average tenure | 1.7yrs |
CEO
Panilam Lakhatariya (41 yo)
1.7yrs
Tenure
₹1,200,000
Compensation
Mr. Panilam Lakhatariya is Chairman & MD of Mono Pharmacare Limited from March 22, 2023. He was Director of Mono Pharmacare Limited from October 17, 2022 to March 22, 2023. He has been an integral part of...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & MD | 1.7yrs | ₹1.20m | 45.44% ₹ 279.8m | |
| Executive Director | 2.1yrs | ₹1.20m | 11.29% ₹ 69.5m | |
| Executive Director | 2.1yrs | ₹480.00k | 0.0030% ₹ 18.5k | |
| Chief Financial Officer | 1.7yrs | no data | no data | |
| Company Secretary & Compliance Officer | 1.9yrs | no data | no data |
1.9yrs
Average Tenure
35yo
Average Age
Experienced Management: MONOPHARMA's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & MD | 2.1yrs | ₹1.20m | 45.44% ₹ 279.8m | |
| Executive Director | 2.1yrs | ₹1.20m | 11.29% ₹ 69.5m | |
| Executive Director | 2.1yrs | ₹480.00k | 0.0030% ₹ 18.5k | |
| Independent Non-Executive Director | 1.7yrs | no data | no data | |
| Non-Executive Director | 1.7yrs | no data | no data | |
| Independent Non-Executive Director | 1.7yrs | no data | no data | |
| Independent Director | less than a year | no data | no data |
1.7yrs
Average Tenure
40.5yo
Average Age
Experienced Board: MONOPHARMA's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.